Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Leray

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Revue Neurologique|February 29, 2024
Prevalence of multiple sclerosis in France in 2021: Data from the French health insurance databaseC Pierret, M Mainguy, E Leray
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 18, 2011
Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: a 5-year prospective studyE Le Page, E Leray, G Edan, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 7, 2020
Use of healthcare services by patients with multiple sclerosis in France over 2010-2015: a nationwide population-based study using health administrative dataJ Roux, A Guilleux, M Lefort, et al.
Revue Neurologique|January 1, 2016
Epidemiology of multiple sclerosisE Leray, T Moreau, A Fromont, et al.
Revue Neurologique|June 6, 2025
Data linkage between the French multiple sclerosis cohort (OFSEP) and the French national health insurance database (SNDS)E Leray, E Drezen, R Casey, et al.
Gynecologie, Obstetrique & Fertilite|October 6, 2007
[Increased risk of relapse in multiple sclerosis patients after ovarian stimulation for in vitro fertilization]D-A Laplaud, F Lefrère, E Leray, et al.
Revue Neurologique|July 13, 2021
Disease-modifying therapy usage in patients with multiple sclerosis in France: A 6-year population-based studyS Leblanc, J Roux, H Tillaut, et al.
European Journal of Neurology|December 18, 2014
Ten-year prognosis in multiple sclerosis: a better outcome in relapsing-remitting patients but not in primary progressive patientsA Kerbrat, S Hamonic, E Leray, et al.
Revue Neurologique|January 1, 2016
Air pollution, a rising environmental risk factor for cognition, neuroinflammation and neurodegeneration: The clinical impact on children and beyondL Calderón-Garcidueñas, E Leray, P Heydarpour, et al.
Revue Neurologique|April 6, 2024
Impact of multiple sclerosis on employment and income: Insights from a random sample representative of private sector employees in France using longitudinal administrative dataE Leray, C Regaert, E Duguet, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Revue Neurologique|February 29, 2024
Prevalence of multiple sclerosis in France in 2021: Data from the French health insurance databaseC Pierret, M Mainguy, E Leray
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 18, 2011
Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: a 5-year prospective studyE Le Page, E Leray, G Edan, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 7, 2020
Use of healthcare services by patients with multiple sclerosis in France over 2010-2015: a nationwide population-based study using health administrative dataJ Roux, A Guilleux, M Lefort, et al.
Revue Neurologique|January 1, 2016
Epidemiology of multiple sclerosisE Leray, T Moreau, A Fromont, et al.
Revue Neurologique|June 6, 2025
Data linkage between the French multiple sclerosis cohort (OFSEP) and the French national health insurance database (SNDS)E Leray, E Drezen, R Casey, et al.
Gynecologie, Obstetrique & Fertilite|October 6, 2007
[Increased risk of relapse in multiple sclerosis patients after ovarian stimulation for in vitro fertilization]D-A Laplaud, F Lefrère, E Leray, et al.
Revue Neurologique|July 13, 2021
Disease-modifying therapy usage in patients with multiple sclerosis in France: A 6-year population-based studyS Leblanc, J Roux, H Tillaut, et al.
European Journal of Neurology|December 18, 2014
Ten-year prognosis in multiple sclerosis: a better outcome in relapsing-remitting patients but not in primary progressive patientsA Kerbrat, S Hamonic, E Leray, et al.
Revue Neurologique|January 1, 2016
Air pollution, a rising environmental risk factor for cognition, neuroinflammation and neurodegeneration: The clinical impact on children and beyondL Calderón-Garcidueñas, E Leray, P Heydarpour, et al.
Revue Neurologique|April 6, 2024
Impact of multiple sclerosis on employment and income: Insights from a random sample representative of private sector employees in France using longitudinal administrative dataE Leray, C Regaert, E Duguet, et al.
Pageof 4